Determination of specific activity of recombinant hirudin using a thrombin titration method /

Determination of specific activity of recombinant hirudin using a thrombin titration method /

42

Bibliographic Details
Main Authors:	235441 Iyer, Lalitha, Fareed, Jawed
Format:
Subjects:	Antithrombins Anticoagulants (Medicine)

Similar Items

Recombinant hirudin : a specific thrombin inhibiting anticoagulant for hemodialysis /
by: Vanholder, Raymond C.

Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin : comparison with heparin and recombinant hirudin /
by: Berry, Christopher N.

Production of biologically active hirudin in plant seeds using oleosin partitioning /
by: Parmenter, D. L.

Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae/
by: Lehman, E. Dale

The complete amino acid sequence of a hirudin variant from the leech Hirudinaria manillensis /
by: Electricwala, Asgar

A simple activity assay for thrombin and hirudin /
by: 350239 Dang, Q. D., et al.

Thrombin inhibition of bloodsucking animals /
by: Dodt, Johannes

Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms /
by: Priestle, John P.

Hirudins : antithrombin anticoagulants/
by: 245873 Stringer, Kathleen A., et al.

DDAVP reduces bleeding during continued hirudin administration in the rabbit/
by: 314772 Bove, Christina M., et al.

Identification and characterization of hirudin-HN, a new thrombin inhibitor, from the salivary glands of Hirudo nipponia
by: Boxing Cheng, et al.
Published: (2019-09-01)

Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model /
by: Walenga, J. M.

Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile /
by: Tapparelli, Carlo

Isolation and characterization of the tsetse thrombin inhibitor : a potent antithrombotic peptide from the saliva of glossina morsitans morsitans /
by: Capello, Michael

Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
by: Meghan M. Chlebowski, et al.
Published: (2020-01-01)

Production of disulfide-linked hirudin dimer by in vitro folding /
by: Chang, Jui-Yoa

Pharmacological properties of hirudin and its derivatives : potential clinical advantages over heparin /
by: 422288 Monreal, Manuel, et al.

Antithrombin and Its Role in Host Defense and Inflammation
by: Christine Schlömmer, et al.
Published: (2021-04-01)

The structure of a complex of recombinant Hirudin and human &-thrombin /

Hirudin as an inhibitor thrombin /
by: 339177 Markwardt, Fritz

Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assay
by: Audrey Carlo, et al.
Published: (2022-07-01)

Increased thrombin activatable fibrinolysis inhibitor activity is associated with hypofibrinolysis in dogs with sepsis
by: Katherine E. Sotos, et al.
Published: (2023-02-01)

Pulmonary Embolism and vascular injury: What is the role of thrombin?
by: Filip A Konecny
Published: (2007-08-01)

Kinetics of the inhibition of thrombin by hirudin /
by: 236620 Stone, Stuart R., et al.

On the isolation of the thrombin inhibitor hirudin /
by: 421393 Walsmann, Peter, et al.

Evaluation of Serum Level of Thrombin-antithrombin III in Preterm Labors
by: Minoo Movahedi, et al.
Published: (2012-03-01)

Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors
by: Takumi Tsuchida, et al.
Published: (2022-05-01)

Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods
by: Réka Gindele, et al.
Published: (2021-04-01)

Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan
by: Kohei Taniguchi, et al.
Published: (2020-09-01)

Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer
by: Cornelia Englisch, et al.
Published: (2022-12-01)

Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics
by: Sara Reda, et al.
Published: (2021-02-01)

Primary prophylaxis of venous thromboembolic disease with direct oral anticoagulants in patients with severe inherited thrombophilia
by: Evelien Krumb, et al.
Published: (2021-02-01)

Influence of Fucoidans on Hemostatic System
by: Mikhail V. Kiselevskiy, et al.
Published: (2013-07-01)

The Effect of Signal Sequence and His-tags on the Expression and Anti-Thrombin Activity of Recombinant Hirudin
by: Shahin Hadadian, et al.
Published: (2021-06-01)

New Insights in Thrombin Inhibition Structure–Activity Relationships by Characterization of Octadecasaccharides from Low Molecular Weight Heparin
by: Pierre A. J. Mourier, et al.
Published: (2017-03-01)

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants
by: Myrthe M. A. Toorop, et al.
Published: (2020-05-01)

Effects of sample matrix in the measurement of antithrombin by LC-MS: A role for immunocapture
by: M. Kruijt, et al.
Published: (2023-01-01)

Apixaban therapy in a pregnant woman with heparin-induced thrombocytopenia and venous thromboembolic events caused by congenital antithrombin deficiency: A case report
by: Mayuko Komori, et al.
Published: (2020-07-01)

Effect of plasma thrombin-antithrombin complex on ischemic stroke: a systematic review and meta-analysis
by: Peipei Song, et al.
Published: (2023-02-01)

Coronary arterial bypass surgery with beating heart in a patient with heparin-induced thrombocytopenia: Usage of thrombin inhibitor (Lepirudin; r-hirudin)
by: Erkut Bilgehan, et al.
Published: (2010-04-01)